1.860USD+2.48%Mkt Cap: 561.83M USDP/E: —Last update: 2026-06-01
ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy wi…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap561.83M USD
Enterprise Value1.44B USD
Revenue (TTM)889.00K USD
Gross Profit889.00K USD
Net Income (TTM)-68.99M USD
Revenue/Share0.0060 USD
Last Price1.860 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees231
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.18
PEG—
EV/EBITDA-8.89
EV/Revenue1618.89
P/S621.79
P/B-0.25
EPS (TTM)-0.53
EPS (Forward)-0.58
52W Range
0.540020% of range7.130
52W High7.130 USD
52W Low0.5400 USD
Profitability
Gross Margin100.00%
Oper. Margin-19881.86%
EBITDA Margin0.00%
Profit Margin-7725.20%
ROE6.82%
ROA-20.56%
Growth
Revenue Growth-1.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-120.12M USD
CapEx (TTM)15.20M USD
FCF Margin-8844.42%
FCF Yield-13.99%
Net Debt-221.16M USD
Net Debt/EBITDA1.37
Balance Sheet
Debt/Equity-0.00
Current Ratio9.06
Quick Ratio8.71
Book Value/Sh-7.2110 USD
Cash/Share1.096 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)6.250 USD
Target Range1.000 USD – 12.00 USD
# Analysts6
Ownership
Shares Out.205.20M
Float156.93M
Insiders47.64%
Institutions24.24%
Short Interest
Short Ratio23.7d
Short % Float12.69%
Short % Out.9.38%
Shares Short19.24M
Short (prev mo.)17.60M
Technical
SMA 501.854 (+0.3%)
SMA 2002.290 (-18.8%)
Beta1.75
S&P 52W Chg27.70%
Avg Vol (30d)755.27K
Avg Vol (10d)985.53K
Technical Indicators
RSI (14)50.7
MACD-0.0383
MACD Signal-0.0564
MACD Hist.+0.0182
BB Upper1.997 USD
BB Middle1.779 USD
BB Lower1.562 USD
BB Width24.43%
ATR (14)0.1235 USD
Vol Ratio (20d)0.90x